Agreement Between High-Resolution Computed Tomography and Pathological Tumor Size of Lung Adenocarcinoma: Influence of Ground Glass Opacity Ratio

Hongliang Sun; Yanyan Xu; Zhenrong Zhang; Wu Wang

doi:10.5812/iranjradiol.22027

Agreement Between High-Resolution Computed Tomography and Pathological Tumor Size of Lung Adenocarcinoma: Influence of Ground Glass Opacity Ratio

Hongliang Sun ^{1
, *} , Yanyan Xu ¹ , Zhenrong Zhang ² and Wu Wang ¹

Authors Information

¹ Department of Radiology, China-Japan Friendship Hospital, Beijing, China

² Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China

Article information

Iranian Journal of Radiology: October 2017, 14 (4); e22027
Published Online: October 7, 2017
Article Type: Research Article
Received: January 13, 2017
Revised: February 11, 2017
Accepted: March 18, 2017
DOI: 10.5812/iranjradiol.22027

To Cite: Sun H, Xu Y, Zhang Z, Wang W. Agreement Between High-Resolution Computed Tomography and Pathological Tumor Size of Lung Adenocarcinoma: Influence of Ground Glass Opacity Ratio, Iran J Radiol. 2017 ;14(4):e22027. doi: 10.5812/iranjradiol.22027.

Abstract

Patients and Methods: Fifty-five patients diagnosed with lung adenocarcinoma manifesting as SSN on HRCT were retrospectively analyzed. The pathological lesion size was 3 cm or less in the largest dimension. The largest diameter of the lesion and the largest diameter of the solid component were measured on axial HRCT scans by two radiologists. Simultaneously, the largest diameter of the lesion was also determined using computer-aided software, and GGO ratio was calculated. The correlation of GGO ratio with the discrepancy between HRCT tumor size and pathological tumor size was analyzed using Pearson’s/Spearman’s rank correlation tests.

Copyright © 2017, Iranian Journal of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Background

With the development of chest CT, in particular high-resolution computed tomography (HRCT), for screening high-risk populations for lung cancer, the sensitivity of sub-solid pulmonary nodule (SSN) detection is gradually increased. On HRCT scans, sub-solid pulmonary nodules manifest as pure ground glass nodule (GGN) or part-solid nodule. There is evidence that SSNs have a higher probability of becoming malignant than solid nodules. Henschke et al. (1) reported that 63% of the part-solid nodules are malignant, while kim et al. (2) reported that up to 81% of persistent SSNs are malignant. Most of persistent SSNs are pathologically diagnosed as lung adenocarcinoma (2).

According to the 7th edition of the tumor-node-metastasis (TNM) staging system for all solid tumors, the size of the tumor is one of the important factors that influence the prognosis of patients with lung adenocarcinoma, and the largest diameter of the tumor is a quantitative index reflecting the size of the tumor. According to the TNM staging system, ground glass opacity (GGO) component should be included when measuring the largest diameter of tumor of lung adenocarcinoma manifesting as SSN, but SSN-type and solid nodule-type lung adenocarcinomas have different prognoses even through the same T stage (i.e., the same largest diameter), and with the increase in GGO ratio, SSN-type lung adenocarcinoma has a better prognosis (3). On HRCT scans, GGO component pathologically represents clara cells or atypical proliferating alveolar epithelial type II cells with lepidic growth, but without interstitial infiltrates (4). Inclusion of GGO component when measuring the largest diameter of tumor will overestimate the T factor (5). Murakawa et al. (5) performed a study of patients with T1-2N0M0 and found that solid component size measured by CT influences tumor recurrence and survival rate. However, GGO component shows little influence on these two indices. Therefore, it is likely to be more significant to measure the largest diameter of solid component during the T stage of a tumor. According to the criteria for lung adenocarcinoma classification issued by international association for the study of lung cancer, American thoracic society, and European respiratory society (IASLC/ATS/ERS) in 2011, solid component should be included when measuring the size of lesions (6). The criteria for lung adenocarcinoma classification are also an important index used to select the clinical treatment method of SSNs detected by HRCT (7). However, no matter for tumor T staging or for pathological classification, the largest diameter of tumor is determined by pathological measurement, which can be achieved postoperatively, and therefore, the largest diameter of tumor is not convincible evidence for preparation of individualized treatment program and prognosis judgment. HRCT is an important method for diagnosing lung adenocarcinoma manifesting as SSN. Few studies have been reported regarding the correlation between HRCT and pathological measurements of the size of SSNs, and the discrepancy between these two measurements greatly influences tumor classification and prognosis judgment. The size of tumors of the abdomen and pelvis, such as cervical cancer (8-10) is consistent between CT and pathological measurements, but as for non-small cell lung cancer, CT tumor size is slightly larger than pathological tumor size (11, 12), which occurs possibly because of alveolar collapse during pathological measurement, different fixations of pathologic specimen, and the difficulty in discriminating the boundary between fibrous connective tissue and tumor tissue on HRCT scans. Lee et al. (13) reported that the largest diameter of GGNs measured by HRCT was significantly greater than that measured pathologically (P < 0.0001), but they did not demonstrate the influence of GGO ratio on the discrepancy between these two measurements.

2. Objectives

3. Patients and Methods

3.1. Case Selection

The study protocol was approved by the institutional review board. Sixty-four patients with pathologically diagnosed lung adenocarcinoma manifesting as SSNs on HRCT scans who received surgical treatment between December 2010 and December 2013 were retrospectively analyzed. The size of SSNs was 3 cm or less in the largest dimension. Patients who corresponded to one of the following criteria were excluded from this study: (1) time interval between scanning and surgery over 1 month (n = 2), (2) CT slice thickness > 2 mm (n = 4), (3) presence of large intrapulmonary air containing space on CT image of the lesion (n = 3), and 55 patients were included in the final analysis. These 55 patients, consisting of 19 males and 36 females, were aged 61 years (range, 26 - 85 years). All these patients underwent pulmonary lobectomy. The time interval between HRCT examination and surgery was 14.2 ± 12.5 days.

3.2. Imaging Examination

The included 55 patients were subjected to non-contrast enhanced CT or contrast enhanced CT scans on a 256-slice multidetector scanner (Brilliance iCT; Philips Medical Systems, Best, The Netherlands). The tube voltage was 120 kV and tube current 200 mAs. The scan range was from supraclavicular fossa to bilateral lung base and scans were initiated after a deep inspiration. High-frequency algorithm was used, with a slice thickness of 0.9 mm and interval of 0.45 mm. Image matrix was 512 × 512, field of view 350 mm, window width 1300 HU, and window level -450 HU. All data were transferred to a workstation (Extended Brilliance Workshop 4.52, Philips Healthcare Systems) for post-processing.

3.3. Post-Processing

The largest diameter of tumor and the largest diameter of the solid component on the axial CT scans were manually measured by two radiologists. The largest diameter of SSNs was also measured using semi-automated analysis software equipped by the EBW 4.52 workstation. According to a previously described method (4), the GGO ratio was determined by software semi-automatedly (Figures 1 and 2). The GGO component within the SSN was taken as a region of interest. The lesion contour was delineated and then adjusted manually to keep away the vascular structure.

Figure 1. Semiautomated segmentation and volume measurement of sub-solid nodule (SSN) in a 63-year-old woman. Segmentation of solid portion and ground-glass portion on lung window (red line: SSN contour; blue line: the contour of the inner solid portion).

Figure 2. Semiautomated segmentation and volume measurement of subsolid nodule (SSN) in a 63-year-old woman. Corresponding nodule segmentation on volume tissue segmentation software (purple: solid portion in SSN; pink: ground-glass portion in SSN). Thus, the ground glass opacity (GGO) ratio of this invasive adenocarcinoma was 44.75% (Volume _GGO/Volume_SSN: [4571.5 - 2525.7]/4571.5).

3.4. Pathological Measurement

The surgically resected specimens were fixed using 10% formalin. The largest diameter of the lesion was gauged. Pathological diagnosis was made according to international multidisciplinary classification of lung adenocarcinoma issued in 2011 (6).

3.5. Statistical Analysis

The largest diameter of the lesion measured manually (Dm) and semi-automatically (Da) on HRCT images and the largest diameter of the lesion measured pathologically were compared using a paired t-test. The correlation between HRCT and pathological measurements was analyzed using Pearson’s/Spearman’s rank correlation tests. The consistency between different radiologists was tested using intraclass correlation coefficient (ICC) and Bland-Altman analysis. The correlation of GGO ratio (R) versus discrepancy between HRCT and pathological measurements, i.e., Dm-pathology diameter (Dp) or Da-Dp, was analyzed using Spearman’s rank correlation method. All statistical analyses were made using SPSS 17.0 (SPSS, Chicago, IL, USA) and MedCalc 12.1.4.0 (MedCalc Software, Mariakerke, Belgium) software. A level of P < 0.05 was considered statistically significant.

4. Results

Fifty-five SSNs consisted of five pure GGNs and 50 part solid nodules. These 55 lesions were pathologically classified as adenocarcinoma in situ (n = 4), minimally invasive adenocarcinoma (n = 5), and invasive adenocarcinoma (n = 46; including 14 cases of lepidic predominant adenocarcinoma and 32 cases of invasive adenocarcinomas with lepidic growth). The mean size of the SSNs was 2.23 ± 0.62 cm for manual measurement on HRCT, 2.39 ± 0.64 cm for semi-automatic (software) measurement on HRCT, and 1.79 ± 0.64 cm for pathological measurement (Table 1). The correlation coefficient was 0.935, 0.833, and 0.813 for manual measurement versus semi-automatic measurement, manual measurement versus pathological measurement, and semi-automatic measurement versus pathological measurement, respectively. There was favorable consistency between manual and semi-automatic measurements on HRCT images (Table 2). The size of tumor measured manually and semi-automatically on HRCT image was respectively 0.44 and 0.61 cm greater than that measured pathologically. The 95% limits of agreement displayed by Bland-Altman plots are shown in Figures 3 and 4. The correlation coefficient for GGO ratio (R) versus the discrepancy between HRCT and pathological measurements, i.e., Dm-Dp or Da-Dp, was 0.474 and 0.457, respectively (Figures 5 and 6).

Table 1. High-Resolution Computed Tomography and Pathological Measurements of Tumor Size

Measurement Method	Minimum, cm	Maximum, cm	Mean, cm	SD
Manual	1.00	4.30	2.23	0.62
Semi-automatic	1.10	4.40	2.41	0.64
Pathological	0.50	3.00	1.79	0.64

Abbreviations: ICC, intraclass correlation coefficient ; SD, Standard deviation.

Table 2. Agreement of the Manual and Semi-Automatic Measurements Regarding the Largest Diameter of a Tumor Between Two Radiologists

Measurement Method	Inter-Observer Difference, cm		t	ICC (95% Confidence Interval)
	Mean ± SD	95% limits of agreement (%)
Manual	0.06182 ± 0.15810	(-10.7 , 16.1)	2.900	0.9826 (0.9702 - 0.9898)
Semi-automatic	-0.03636 ± 0.18794	(-17.1 , 14.3)	-1.435	0.9818 (0.9688 - 0.9894)

Abbreviations: ICC,intraclass correlation coefficient ; SD, Standard deviation.

Figure 3. A - C, There was a positive correlation between manual (Dm) and semi-automatic (Da) measurements (r = 0.935), between manual (Dm) and pathological measurements (Dp; r = 0.833) and between semi-automatic (Da) and pathological measurements (Dp; r = 0.813) of the largest tumor diameter.

Figure 4. A - B. Bland-Altman plots used to measure agreement with repeated measures between manual and semi-automatic measurements. The mean difference between the two measurements is shown with a solid line; the lower and upper 95% limits of agreement are the dashed lines at (-%10.7 , %16.1) for A and (-%17.1 , %14.3) for B. The magnitude of the difference between manual and semi-automatic measurements regarding average tumor size does not seem to differ since there is no apparent pattern on the plot.

Figure 5. Correlation of ground glass opacity ratio with the discrepancy between manual measurement (Dm) and pathological measurement (Dp) of the largest diameter of a tumor (r = 0.474).

Figure 6. Correlation of ground glass opacity ratio with the discrepancy between semi-automatic measurement (Da) and pathological measurement (Dp) of the largest tumor diameter (r = 0.457).

5. Discussion

Results from this study demonstrated that as for lung adenocarcinoma manifesting as SSN, the largest diameter of SSN measured on HRCT image was greater than that measured pathologically, but there was a positive correlation between HRCT and pathological measurements; secondly, the discrepancy between HRCT and pathological measurements was correlated with the ratio of GGO in the SSN. These findings to a certain degree help explain the reason why the largest diameter of a tumor measured pathologically was smaller than that measured manually or semi-automatically on HRCT scans, and further suggest that alveolar collapse is likely to be one of important factors that lead to the discrepancy between HRCT and pathological measurements.

For patients with lung cancer, the size of tumor is one of important factors influencing the prognosis. According to the latest TNM staging system, the largest tumor diameter measured pathologically is a reference for evaluating the stage of a tumor, however, in the clinic, CT measurement of the largest tumor diameter is an important method used to preoperatively evaluate the stage of a tumor, and the clinical stage and the pathological stage are not always consistent (11). This is also true for the lung adenocarcinoma manifesting as SSN.

The discrepancy of the largest diameter of SSN between HRCT and pathological measurements has specific characteristics and interpretation. It is difficult to gauge the largest diameter of SSN on HRCT image owing to the unclear boundary between SSN and the surrounding normal lung tissue and irregular SSN morphology. Isaka et al (14) demonstrated that after specimen fixation by formalin, pathological tumor size was significantly less than CT tumor size, and the discrepancy between CT and pathological measurements in GGO ratio > 50% tumors was significantly larger than in GGO ratio < 50% tumors. Therefore, they suggest that for the pathologically diagnosed lung adenocarcinoma manifesting as SSN, the resected lung specimen should be sufficiently inflated with physical saline to prevent the shrinking of the lepidic component in the tumor, because under the condition of sufficient inflation, there was a well correlation between CT tumor size and pathological tumor size. These findings were consistent with some results from the present study. This confirms that alveolar collapse is a factor leading to the discrepancy between CT tumor size and pathological tumor size and GGO ratio greatly influences the discordance (14).

Tumor clinical stage and pathological stage are not completely consistent. As for lung adenocarcinoma manifesting as SSN, GGO ratio is another important factor related to patient’s prognosis, and it is also one of important factors that influence the prognosis of lung adenocarcinoma in addition to TNM staging. Results from this study have demonstrated that as for SSN, GGO ratio to a certain degree contributes to the discrepancy between tumor clinical stage and pathological stage, i.e., higher GGO ratio indicates a smaller pathological tumor size, which to a certain degree suggests a better prognosis of lung adenocarcinoma manifesting as SSN (15, 16). It is worth noting that the correlation between manual and pathological measurements of tumor size is superior to that between semi-automatic and pathological measurements of tumor size. This occurs possibly because the lung nodule analysis software can automatically measure the largest diameter of an irregular nodule three-dimensionally, and the largest diameter of SSN measured manually is always less than that measured semi-automatically; however, pathological tumor size is often determined by randomly selecting the subjectively considered largest diameter on tissue specimens, and pathological tumor size is often less than the length of the true largest diameter of a tumor.

Vazquez et al. (15) conducted a study regarding low-dose CT screening for lung cancer and found that with the reduction in lepidic components, GGO ratio on HRCT decreases, and simultaneously the number of patients with tumors invading pleura, blood vessels, lymphatic vessels and bronchi increases proportionally. Nakata et al. (3) analyzed the imaging data of 146 T1N0M0 peripheral non-small cell lung cancers and they concluded that GGO ratio well correlated with histological classification, pathological invasiveness and prognosis, tumors with GGO ratio > 50% have a better prognosis because patients with tumors that have GGO ratio > 50% can receive limited surgical resection, for example pulmonary lobectomy or segmentectomy. Based on evidence that in patients with lung adenocarcinoma, GGO ratio and vessel invasion by the lesion on HRCT have a great predictive value, the largest diameter or volume of GGO should be considered when measuring GGO ratio, and use of analysis software for GGO volume measurement is reproducible (17, 18). Oda et al. (19) calculated the volume-doubling time of SSN and demonstrated that the largest diameter of SSN was not significantly correlated with the doubling time of tumor (r = -0.19, P = 0.19). Therefore, this suggests that to a certain degree the largest diameter of SSN is of limited value in tumor prognosis evaluation. On the contrary, there is a certain correlation between lesion density and doubling time (r = -0.57, P < 0.01), demonstrating that the ratio of solid component is of important value for evaluating tumor prognosis (19). As for part solid nodule, the largest diameter of the solid component is considered as a more reliable index used for evaluating tumor prognosis (5). Lee et al. (13) reported that the size of solid component on CT image well correlates with pathological tumor size. As for SSN, the ratio of solid component in the total lesion volume on CT image is one of the important factors influencing patient’s prognosis in addition to the TNM staging. Therefore, when evaluating SSN, the size and ratio of solid component are important supplements for simple measurement of the largest diameter of SSN and are important indices for prognosis evaluation in addition to the TNM staging. With continuing improvement in CT technology, computer-aided measurement of SSN has attracted increasing attention, and the accuracy of SSN parameter measurement is also gradually increased. Sumikawa et al. (20) analyzed the records of 49 patients with lung adenocarcinoma manifesting as SSN smaller than 2 cm in diameter. Measurement of solid component ratio using semi-automated lung nodule analysis software is reproducible, and semi-automatic measurement of solid component ratio is more reproducible than semi-automatic measurement of the largest diameter and area ratios (20).

This study has several limitations. First, it is a retrospective study, selection bias exists in patient inclusion, the proportion of pure SSN cases is very low, and the majority of included cases have invasive adenocarcinoma with lepidic growth, the largest diameter of the invasive adenocarcinomas with lepidic growth is greater than the pure GGN, and relatively speaking, the measurement bias is small in pure GGN. Second, pathological tumor size is determined by measuring the largest diameter of tumor based on a randomly selected plane, and it is difficult to ensure that pathological tumor size correspond to semi-automatically measured tumor size one by one. In addition, the size of pathologically infiltrated component was not measured because this was not performed in the routine pathological section measurement. Third, pathological measurement was performed after formalin fixation, so it is difficult to avoid the influence of formalin fixation on the shrinkage of the tissue. Fourth, the solid component on HRCT cannot completely correspond to the infiltrated component on pathological section, because alveolar collapse and fibrous connective tissue proliferation also manifest as solid component on HRCT scans, which influence SSN measurement in some diseases.

5.1. In Conclusion

Taken together, HRCT measurement of the largest diameter of SSN correlates with its pathological measurement, but HRCT tumor size is greater than pathological tumor size. GGO ratio correlates with the discrepancy between HRCT tumor size and pathological tumor size, which to a certain degree explains that alveolar collapse is one of causes of the discordance between HRCT and pathological measurements.

Footnotes

References

1. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol. 2002;178(5):1053-7. doi: 10.2214/ajr.178.5.1781053. [PubMed: 11959700].
2. Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007;245(1):267-75. doi: 10.1148/radiol.2451061682. [PubMed: 17885195].
3. Nakata M, Sawada S, Yamashita M, Saeki H, Kurita A, Takashima S, et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129(6):1226-31. doi: 10.1016/j.jtcvs.2004.10.032. [PubMed: 15942561].
4. Lee HJ, Kim YT, Kang CH, Zhao B, Tan Y, Schwartz LH, et al. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes. Radiology. 2013;268(1):254-64. doi: 10.1148/radiol.13112553. [PubMed: 23468578].
5. Murakawa T, Konoeda C, Ito T, Inoue Y, Sano A, Nagayama K, et al. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma. Eur J Cardiothorac Surg. 2013;43(5):925-32. doi: 10.1093/ejcts/ezs467. [PubMed: 23047267].
6. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. [PubMed: 21252716].
7. Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM, Pistolesi M, Goo JM, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology. 2013;266(1):304-17. doi: 10.1148/radiol.12120628. [PubMed: 23070270].
8. Botea F, Marconi M, Lutman F, Balzarini L, Roncalli M, Montorsi M, et al. Radiological estimation of size in colorectal liver metastases: is it reliable? Comparison with post-resectional measurements. Updates Surg. 2010;62(1):21-6. doi: 10.1007/s13304-010-0004-0. [PubMed: 20845097].
9. Torkzad M, Lindholm J, Martling A, Blomqvist L. Retrospective measurement of different size parameters of non-radiated rectal cancer on MR images and pathology slides and their comparison. Eur Radiol. 2003;13(10):2271-7. doi: 10.1007/s00330-003-1898-4. [PubMed: 12740710].
10. Innocenti P, Fiumicelli D, Agostini S, Savino L, Taddei G, Santoni R, et al. Magnetic resonance imaging in the measurement of clinical stage IB cervical carcinoma. Eur J Radiol. 1996;23(3):222-7. doi: 10.1016/S0720-048X(96)00773-5. [PubMed: 9003929].
11. Ridge CA, Huang J, Cardoza S, Zabor EC, Moskowitz CS, Zakowski MF, et al. Comparison of multiplanar reformatted CT lung tumor measurements to axial tumor measurement alone: impact on maximal tumor dimension and T stage. AJR Am J Roentgenol. 2013;201(5):959-63. doi: 10.2214/AJR.12.10033. [PubMed: 24147464].
12. Lampen-Sachar K, Zhao B, Zheng J, Moskowitz CS, Schwartz LH, Zakowski MF, et al. Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas. Lung Cancer. 2012;75(3):332-5. doi: 10.1016/j.lungcan.2011.08.001. [PubMed: 21890229].
13. Lee KH, Goo JM, Park SJ, Wi JY, Chung DH, Go H, et al. Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules. J Thorac Oncol. 2014;9(1):74-82. doi: 10.1097/JTO.0000000000000019. [PubMed: 24346095].
14. Isaka T, Yokose T, Ito H, Imamura N, Watanabe M, Imai K, et al. Comparison between CT tumor size and pathological tumor size in frozen section examinations of lung adenocarcinoma. Lung Cancer. 2014;85(1):40-6. doi: 10.1016/j.lungcan.2014.03.023. [PubMed: 24751107].
15. Vazquez M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD, et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer. 2009;64(2):148-54. doi: 10.1016/j.lungcan.2008.08.009. [PubMed: 18951650].
16. Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg. 2006;81(2):413-9. doi: 10.1016/j.athoracsur.2005.07.058. [PubMed: 16427823].
17. Matsuguma H, Oki I, Nakahara R, Suzuki H, Kasai T, Kamiyama Y, et al. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2013;95(6):1878-84. doi: 10.1016/j.athoracsur.2013.02.022. [PubMed: 23618519].
18. Tateishi U, Uno H, Yonemori K, Satake M, Takeuchi M, Arai Y. Prediction of lung adenocarcinoma without vessel invasion: a CT scan volumetric analysis. Chest. 2005;128(5):3276-83. doi: 10.1378/chest.128.5.3276. [PubMed: 16304272].
19. Oda S, Awai K, Murao K, Ozawa A, Utsunomiya D, Yanaga Y, et al. Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer-aided three-dimensional volumetry. Acad Radiol. 2011;18(1):63-9. doi: 10.1016/j.acra.2010.08.022. [PubMed: 21145028].
20. Sumikawa H, Johkoh T, Nagareda T, Sekiguchi J, Matsuo K, Fujita Y, et al. Pulmonary adenocarcinomas with ground-glass attenuation on thin-section CT: quantification by three-dimensional image analyzing method. Eur J Radiol. 2008;65(1):104-11. doi: 10.1016/j.ejrad.2007.03.013. [PubMed: 17466475].